[
  {
    "ts": null,
    "headline": "Columbia Dividend Income Fund Q2 2025 Commentary",
    "summary": "Columbia Threadneedle Investments reports Q2 underperformance for its Dividend Income Fund amid tech and healthcare headwinds. See how quality stocks remain central.",
    "url": "https://finnhub.io/api/news?id=abdcfc7414c024b4a1ef96ab2faac9bbdfb29f442859ed22402764565c78c6b5",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755545400,
      "headline": "Columbia Dividend Income Fund Q2 2025 Commentary",
      "id": 136413574,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2206196350/image_2206196350.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Columbia Threadneedle Investments reports Q2 underperformance for its Dividend Income Fund amid tech and healthcare headwinds. See how quality stocks remain central.\n",
      "url": "https://finnhub.io/api/news?id=abdcfc7414c024b4a1ef96ab2faac9bbdfb29f442859ed22402764565c78c6b5"
    }
  },
  {
    "ts": null,
    "headline": "Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know",
    "summary": "Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
    "url": "https://finnhub.io/api/news?id=91652647278ac58ac8719c423e4000d9bb315f5cbfd7ae628835c1c7ba089b06",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755522005,
      "headline": "Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know",
      "id": 136408323,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
      "url": "https://finnhub.io/api/news?id=91652647278ac58ac8719c423e4000d9bb315f5cbfd7ae628835c1c7ba089b06"
    }
  },
  {
    "ts": null,
    "headline": "Here's How You Can Earn $100 In Passive Income By Investing In Johnson & Johnson Stock",
    "summary": "Johnson & Johnson (NYSE:JNJ) is a global healthcare company that researches, develops, and manufactures a wide range of pharmaceutical products, medical devices, and consumer health products. It will report its Q3 2025 earnings on Oct. 14. Wall Street ...",
    "url": "https://finnhub.io/api/news?id=986969e8a6654ff4bdc33b4d7c20215bc41de5b3f33bf9f09ede0d0b0ba73892",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755518462,
      "headline": "Here's How You Can Earn $100 In Passive Income By Investing In Johnson & Johnson Stock",
      "id": 136408324,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (NYSE:JNJ) is a global healthcare company that researches, develops, and manufactures a wide range of pharmaceutical products, medical devices, and consumer health products. It will report its Q3 2025 earnings on Oct. 14. Wall Street ...",
      "url": "https://finnhub.io/api/news?id=986969e8a6654ff4bdc33b4d7c20215bc41de5b3f33bf9f09ede0d0b0ba73892"
    }
  }
]